Activity of Psoralen-Functionalized Nanoscintillators against Cancer Cells upon X-ray Excitation
Authors:
- 9 May 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 5 (6) , 4679-4687
Abstract
We report development of a nanoparticle-based, X-ray-activated anticancer “nanodrug” composed of yttrium oxide (Y2O3) nanoscintillators, a fragment of the HIV-1 TAT peptide, and psoralen. In this formulation, X-ray radiation is absorbed by the Y2O3 nanoscintillators, which then emit UVA light. Absorption of UVA photons by nanoparticle-tethered psoralen has the potential to cross-link adenine and thymine residues in DNA. UVA-induced cross-linking by free psoralen upon activation with UVA light has previously been shown to cause apoptosis in vitro and an immunogenic response in vivo. Studies using the PC-3 human prostate cancer cell line demonstrate that X-ray excitation of these psoralen-functionalized Y2O3 nanoscintillators yields concentration-dependent reductions in cell number when compared to control cultures containing psoralen-free Y2O3 nanoscintillators.Keywords
This publication has 84 references indexed in Scilit:
- In Vitro and In Vivo Investigation on PLA–TPGS Nanoparticles for Controlled and Sustained Small Molecule ChemotherapyPharmaceutical Research, 2008
- SCKs as nanoparticle carriers of doxorubicin: investigation of core composition on the loading, release and cytotoxicity profilesChemical Communications, 2008
- Effect of surface chemistry modification of functional gold nanoparticles on the drug accumulation of cancer cellsJournal of Biomedical Materials Research Part A, 2007
- Characterization of the Theorectical Radiation Dose Enhancement from NanoparticlesTechnology in Cancer Research & Treatment, 2007
- Poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapyInternational Journal of Pharmaceutics, 2007
- Multifunctional Nanoparticles for Combining Ultrasonic Tumor Imaging and Targeted ChemotherapyJNCI: Journal of the National Cancer Institute, 2007
- The Enhancement Effect of Gold Nanoparticles in Drug Delivery and as Biomarkers of Drug‐Resistant Cancer CellsChemMedChem, 2007
- Emerging implications of nanotechnology on cancer diagnostics and therapeuticsCancer, 2006
- Nanoparticles in cancer therapy and diagnosisAdvanced Drug Delivery Reviews, 2002
- Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated NanoparticlesPharmaceutical Research, 1999